‘Dormancy Inhibitors’ Promising for Combating TB

0
86

A novel approach to TB drug discovery has led to the identification of artemisinin and five other ‘dormancy inhibitors’ that could eventually shorten TB treatment and slow the development of resistance, researchers say.
Reuters Health Information